As of September 2026, 130 paid clinical trials are recruiting in Eugene, Oregon. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Eugene offers studies at sites including Willamette Valley Cancer Institute and Research Center for conditions such as Endometrial Cancer, Chronic Lymphocytic Leukemia, Multiple Myeloma, Fallopian Tube Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Researchers run research studies in Eugene, OR at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Willamette Valley Cancer Institute and Research Center | Breast Cancer, Carcinoma, Non-Small-Cell Lung, Chronic Myeloid Leukemia | 13 |
| University of Oregon | Acculturative Stress, Aging, Autism Spectrum Disorder | 10 |
| Oncology Associates of Oregon, P.C. | Advanced/Metastatic Non-Small Cell Lung Cancer, Advanced/Metastatic Urothelial Cancer, Carcinoma, Non-Small Cell Lung | 10 |
| Oncology Associates of Oregon | Multiple Myeloma, B-cell Lymphoma, Breast Neoplasms | 9 |
| Verum Research, LLC | Geographic Atrophy, Diabetic Macular Edema, Geographic Atrophy Secondary to Age-related Macular Degeneration | 7 |
| Willamette Valley Cancer Institute | Acute Myeloid Leukemia (AML), Breast Neoplasms, Low Grade Serous Ovarian Cancer | 5 |
| Oncology Associates of Oregon Willamette Valley Cancer Center | Chronic Lymphocytic Leukemia, CLL, HR+/HER2- Breast Cancer | 4 |
| Chestnut Health Systems | Decision Making, Decision Making, Shared, Implementation Science | 3 |
| Oncology Associates Of Oregon, Pc | Non-small Cell Lung Cancer (NSCLC), Solid Tumors, Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma | 3 |
| Prevention Science Institute | Academic Achievement, Behavior Problems, Clinical High Risk for Psychosis (CHR) | 3 |
| Verum Research LLC | Age-related Macular Degeneration (AMD), Epiretinal Membrane, Geographic Atrophy | 3 |
| Oncology Associates of Oregon, P.C.(Willamette Valley Cancer Institute) (WVCI) | Lung Neoplasm Malignant, Cervical Cancer, Fallopian Tube Cancer | 3 |
| Oncology Associates of Oregon PC | Early Breast Cancer, NSCLC, NSCLC (Advanced Non-small Cell Lung Cancer) | 2 |
| Oncology Associates of Oregon PC Willamette Valley Cancer Institute | Carcinoma, Non-Small-Cell Lung, Multiple Myeloma | 2 |
| Oncology Associates of Oregon, P.C | Breast Cancer, Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma | 2 |
| Pacific Clear Vision Institute | Astigmatism, Bacterial Keratitis, Ectasia of Cornea | 2 |
| Pacific Sports & Spine | Degenerative Conditions of the Lumbar Spine, Degenerative Disc Disease, Disc Degeneration | 2 |
| Pacific Sports and Spine | Degenerative Disc Disease, Osteoarthritis Knee Pain | 2 |
| Pacific Sports and Spine, LLC | Chronic Pain, Pain | 2 |
| Slocum Research & Education Foundation | Avascular Necrosis, Dislocation, Hip, Femoral Neck Fractures | 2 |
| Williamette Valley Cancer Institute and Research Center | Non-small Cell Lung Cancer (NSCLC), Urinary Bladder Neoplasms, Urothelial Cancer | 2 |
| 517 | Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer | 1 |
| AURORA-1 Clinical Site | Chronic Weight Management, Obesity, Overweight | 1 |
| AURORA-2 Clinical Site | Chronic Weight Management, Obesity, Overweight | 1 |
| Arts & Technology Academy | Depression, Disparities, Emotional Regulation | 1 |
Recruiting trials in Eugene grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 130 recruiting clinical trials in Eugene, Oregon listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Eugene compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Eugene include Endometrial Cancer (8), Chronic Lymphocytic Leukemia (7), Multiple Myeloma (6), Fallopian Tube Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Eugene on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Eugene include Willamette Valley Cancer Institute and Research Center, University of Oregon, Oncology Associates of Oregon, P.C., among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Eugene are Cancer & tumors (62), Eye & vision (9), Mental health & behavior (7). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.